(Q44631284)

4 December 2017

title

Eye changes in connection with neuroleptic treatment especially concerning phenothiazines and thioxanthenes (English)

1 reference

4 December 2017

K. Edler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5146713

16 January 2024

C. G. Gottfries

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5146713

16 January 2024

J. Haslund

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5146713

16 January 2024

J. Ravn

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A5146713

16 January 2024

language of work or name

English

0 references

publication date

1 January 1971

1 reference

full work available at URL

4 December 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1600-0447.1971.tb03695.x

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1971.TB03695.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1600-0447.1971.tb03695.x

16 January 2024

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1971.TB03695.X

Acta Psychiatrica Scandinavica

16 January 2024

published in

1 reference

4 December 2017

volume

47

1 reference

4 December 2017

issue

4

1 reference

4 December 2017

page(s)

377-384

1 reference

Total dosage of chlorpromazine and ocular opacities.

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1971.TB03695.X

Extended trial of thiothixene in chronic psychotic patients

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1971.TB03695.X

OPHTHALMOLOGIC FINDINGS IN PATIENTS ON LONG-TERM CHLORPROMAZINE THERAPY

16 January 2024

2

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1971.TB03695.X

Observations on ocular pigment and pigmentation

16 January 2024

4

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1971.TB03695.X

Ocular changes associated with chlorpromazine therapy. A preliminary report

16 January 2024

6

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1971.TB03695.X

Chlorpromazine corneal toxicity

16 January 2024

9

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1971.TB03695.X

Lens opacities and porphobilinogen-like substance in urine associated with levomepromazine

16 January 2024

10

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1971.TB03695.X

16 January 2024

Melanin pigmentation

11

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1971.TB03695.X

LENTICULAR OPACITIES WITH PROLONGED PHENOTHIAZINE THERAPY: A POTENTIAL HAZARD WITH ALL PHENOTHIAZINE DERIVATIVES

16 January 2024

12

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1971.TB03695.X

Eye and skin changes in psychiatric patients treated with chlorpromazine

16 January 2024

13

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1971.TB03695.X

[RETINAL DAMAGE AFTER TREATMENT WITH CHLORPROTHIXENE]

16 January 2024

14

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1971.TB03695.X

The ocular toxic findings with prolonged and high dosage chlorpromazine intake

16 January 2024

15

1 reference

https://api.crossref.org/works/10.1111/J.1600-0447.1971.TB03695.X

16 January 2024

Identifiers

1 reference

4 December 2017

1 reference